id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-E-5956-0003,FDA,FDA-2017-E-5956,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2017-11-07T05:00:00Z,2017,11,2017-11-07T05:00:00Z,,2017-11-07T14:31:37Z,,0,0,0900006482c545bf
FDA-2017-E-5956-0001,FDA,FDA-2017-E-5956,Patent Extension Application from Pfizer Inc.,Other,Application,2017-09-27T04:00:00Z,2017,9,2017-09-27T04:00:00Z,,2017-09-27T18:02:18Z,,0,0,0900006482b8398b
FDA-2017-E-5956-0002,FDA,FDA-2017-E-5956,U.S. Patent and Trademark Office,Other,Letter(s),2017-09-27T04:00:00Z,2017,9,2017-09-27T04:00:00Z,,2017-09-27T18:07:17Z,,0,0,0900006482b8398e